Annovis Bio (ANVS)
Develops oral buntanetap for Alzheimer's and Parkinson's disease.
$1.28
vs last close+0.01 (+1.19%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 25.47% | 10.85M shares | |
|---|---|---|---|
| 69 holders · as of Jun 30, 2026 | |||
| Insiders | 10.80% | 4.60M shares | |
| 5 holders · as of May 21, 2026 | |||
| Strategic holders | 6.51% | 2.78M shares | |
| 1 holder · as of Aug 14, 2026 | |||
| Other | 57.22% | 24.38M shares | |
| remainder | |||
42.61M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
69 holders · 10.85M shares · 16 new positions · 36 increased · 6 reduced · 10 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Empery Asset Management, LP | 2.40M | 5.64% | +2.40Mnew | Aug 11, 2026 |
| Marshall Wace, LLP | 1.84M | 4.32% | +654.8K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 1.65M | 3.87% | +774.9K | Aug 13, 2026 |
| Tudor Investment Corp et al | 1.36M | 3.19% | +1.36Mnew | Aug 14, 2026 |
| Renaissance Technologies LLC | 1.00M | 2.35% | +654.6K | Aug 13, 2026 |
| Two Sigma Investments, LP | 579.6K | 1.36% | −48.1K | Aug 14, 2026 |
| Geode Capital Management, LLC | 283.8K | 0.67% | +36.3K | Aug 12, 2026 |
| BlackRock, Inc. | 249.9K | 0.59% | +110.3K | Aug 7, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Highbridge Capital Management, LLC | 6.10% | 2.78M | 13G | Aug 14, 2026 |
| Empery Asset Management, LP | 5.64% | 2.40M | 13G | Jul 29, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| May 20, 2026 | Michael B. Hoffmandirector | Purchase · 3 lots | 76,344 | $1.87 | 3,364,883 |
| Apr 2, 2026 | Michael B. Hoffmandirector | Purchase | 713,800 | $2.10 | 3,288,539 |
| Dec 8, 2025 | Michael B. Hoffmandirector | Purchase · 2 lots | 45,000 | $4.31 | 2,574,739 |
| Nov 24, 2025 | Michael B. Hoffmandirector | Purchase · 4 lots | 39,200 | $4.08 | 2,529,739 |
| Nov 21, 2025 | Michael B. Hoffmandirector | Purchase · 2 lots | 20,000 | $3.50 | 2,490,539 |
| Nov 14, 2025 | Michael B. Hoffmandirector | Purchase | 15,000 | $2.11 | 2,470,539 |
| Oct 28, 2025 | Michael B. Hoffmandirector | Purchase | 975,610 | $2.05 | 2,455,539 |
| Oct 28, 2025 | Maria-Luisa Maccecchinidirector, officer: President & CEO | Purchase | 97,561 | $2.05 | 1,212,020 |
House and Senate disclosures
Not reported.